Remdesivir (development code GS-5734) is an antiviral drug, a novel nucleotide analogue prodrug. It was developed by Gilead sciences as a treatment for Ebola virus disease and Marburg virus infections, … Continue reading Remdesivir (GS-5734)

Read more